1. Fibrinogen as a major risk factor in cardiovascular disease;Cook;Trends in Pharmac Sci,1990
2. Use of thrombin-like snake venom enzymes in the treatment of vascular occlusive diseases;Furukawa,1990
3. Experimental model of DIC and haemorrhagic diathesis using snake venom enzymes;Kornalík,1989
4. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro;Moore;Eur J Pharmacol,1988
5. Fibrinopeptide A (FPA) and fibrinopeptide B (FPB) induced tissue factor and plasminogen activator expression in human vascular endothelial cells (HUVEC) in vitro;Contrino;Thromb Haemostas,1993